Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

Clinical trial NCT04491370 · RECRUITING

Trial details

NCT number: NCT04491370
Sponsor: New York Medical College
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Lymphoma Burkitt Lymphoma Diffuse Large B Cell Lymphoma Follicular Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Transformed Non-Hodgkin Lymphoma Richter Syndrome Hodgkin Lymphoma

Start date: 2021-08-01
Primary completion: 2026-08-15
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.